/
LFVN
$6.20-$0.42 (-6.34%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$83.5M
13M shares
52-week range
$3.90 – $15.00
21% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Borrow rate
117.54%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-1.10
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $203.2M | $226.0M | $232.9M | $220.2M | $206.4M | $213.4M | $200.2M | $228.5M |
| Cost of revenue | $34.8M | $38.0M | $38.0M | $38.2M | $38.1M | $43.4M | $41.4M | $44.9M |
| Gross profit | $168.4M | $188.0M | $195.0M | $182.0M | $168.3M | $170.0M | $158.7M | $183.7M |
| Gross margin | 82.9% | 83.2% | 83.7% | 82.7% | 81.5% | 79.7% | 79.3% | 80.4% |
| R&D | $1.2M | $1.1M | $0 | $700.0K | $0 | $0 | $0 | $0 |
| Operating income | $10.3M | $9.5M | $15.5M | $17.6M | $7.6M | $4.3M | $4.3M | $12.2M |
| EBITDA | $11.3M | $11.4M | $19.9M | $20.7M | $8.0M | $7.6M | $7.9M | $15.4M |
| Net income | $5.8M | $7.4M | $11.5M | $12.9M | $3.1M | $2.5M | $2.9M | $9.8M |
| Net margin | 2.8% | 3.3% | 5.0% | 5.9% | 1.5% | 1.2% | 1.5% | 4.3% |
| EPS (diluted) | 0.41 | 0.50 | 0.79 | 0.90 | 0.24 | 0.20 | 0.23 | 0.76 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $184M | $0.57 | $0.56–$0.59 | 1 |
| 2027 | $178M | $0.46 | $0.44–$0.47 | 1 |
| 2028 | $165M | $0.41 | $0.40–$0.42 | 1 |
| 2029 | $292M | $1.55 | $1.50–$1.58 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$12.64
Price
$6.20
Implied upside
+104%
Peer comparison
Lifevantage Corporation Common Stock (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
www.lifevantage.com- Employees
- 238
- IPO / List date
- Mar 10, 1997
- HQ
- LEHI, UT
Held by traders on TradeandTell
No one on the platform currently holds LFVN.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 867,704 | $3.7M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 2.98% ($0.18/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-01 | $0.0500 | 2026-06-15 |
| 2026-03-02 | $0.0450 | 2026-03-16 |
| 2025-12-01 | $0.0450 | 2025-12-15 |
| 2025-09-08 | $0.0450 | 2025-09-16 |
| 2025-05-30 | $0.0450 | 2025-06-13 |
| 2025-03-03 | $0.0400 | 2025-03-17 |
| 2024-12-02 | $0.0400 | 2024-12-16 |
| 2024-09-09 | $0.0400 | 2024-09-17 |
| 2024-05-31 | $0.0400 | 2024-06-14 |
| 2024-02-29 | $0.0350 | 2024-03-15 |
Recent trades on TradeandTell
No one on the platform has traded LFVN yet.
